Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs

Oncogene

Volumn 17, Issue 17, 1998, Pages 2235-2249

  Pietras, Richard J ^a   Pegram, Mark D ^a   Finn, Richard S ^a   Maneval, Daniel A ^b   Slamon, Dennis J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GENENTECH INC   (United States)

Author keywords

Breast cancer; Cisplatin; Doxorubicin; HER 2 neu; Monoclonal antibody; Ovarian cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY;

ARTICLE; BLOCKING FACTOR; BREAST CANCER; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOTOXICITY; DNA DRUG COMPLEX; DNA REPAIR; FEMALE; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; ONCOGENE NEU; OVARY CANCER; PRIORITY JOURNAL; RECOMBINANT GENE; REMISSION; REPORTER GENE; TUMOR GROWTH; TUMOR XENOGRAFT; UNSCHEDULED DNA SYNTHESIS;

ANIMALIA; MURINAE;

EID: 0032578797     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202132     Document Type: Article

References (85)

1. Aaronson SA. (1991). Science, 254, 1146-1153.
2. Aboud-Pirak E, Hurwitz E, Pirak ME, Bellot F, Schlessinger J and Sela M. (1988). J. Natl. Cancer Inst., 80, 1605-1611.
3. Aboud-Pirak E, Hurwitz E, Bellot F, Schlessinger J, and Sela M. (1989). Proc. Natl. Acad. Sci. USA, 86, 3778-3781.
4. Allred DC, Clark GM, Tandon AK, Molina R, Tormey DC, Osborne CK, Gilchrist KW, Mansour EG, Abeloff M, Eudey L and McGuire WL. (1992). J. Clin. Oncol., 10, 599-605.
5. Andrews PA, Velury S, Mann SC and Howell SB. (1988). Cancer Res., 48, 68-73.
6. Arteaga CL, Winnier AR, Poirier MC, Lopez-Larraza DM, Shawver LK, Hurd SD and Stewart SJ. (1994). Cancer Res., 54, 3758-3765.
7. Bacus SS, Yarden Y, Oren M, Chin DM, Lyass L, Zelnick CR, Kazarov A, Toyofuku W, Gray-Bablin J, Beerli RR, Hynes NE, Nikiforov M, Haffner R, Gudkov A and Keyomarsi K. (1996). Oncogene, 12, 2535-2547.
8. Bargmann CI, Hung MC and Weinberg RA. (1986). Cell, 45, 649-657.
9. Benz C, Scott G, Sarup J, Johnson R, Tripathy D, Coronado E, Shepard H and Osborne C. (1993). Breast Cancer Res. Treatment, 24, 85-95.
10. Berenbaum MC. (1989). Pharmacol. Rev., 19, 93-138.
11. Boven E, deJong J, Kuiper C, Bast A and van der Vijgh W. (1996). Eur. J. Cancer, 32A, 1382-1387.
12. Campbell RC. (1976). Statistics for Biologists. University Printing House, Cambridge.
13. Canman CE, Gilmer TM, Coutts S and Kastan M. (1995). Genes & Development, 9, 600-611.
14. Carter P, Presta L, Gorman CM, Ridgway JBB, Henner D, Wong WLT, Rowland AM, Knotts C, Carver ME and Shepard HM. (1992). Proc. Natl. Acad. Sci. USA, 89, 4285-4289.
15. Chazin VR, Kaleko M, Miller AD and Slamon DJ. (1992). Oncogene, 7, 1859-1866.
16. Chen C, Oliner J, Zhan Q, Fornace A, Vogelstein B and Kastan M. (1994). Proc. Natl. Acad. Sci. USA, 91, 2684-2688.
17. Chou T-C and Talalay P. (1984). Adv. Enz. Reg., 22, 27-43.
18. Christen RD, Hom DK, Porter DC, Andrews PA, MacLeod CL, Hafstrom L and Howell SB. (1991). J. Clin. Invest., 86, 1632-1640.
19. Chu G. (1994). J. Biol. Chem., 269, 787-790.
20. Coussens L, Yang-Feng TC, Liao YC, Chen E, Gray A, McGrath J, Seeburg PH, Lieberman TA, Schlessinger J, Francke U, Levinson A and Ullrich A. (1985). Science, 230, 1132-1139.
21. Cutts SM, Parsons PG, Sturm RA and Phillips DR. (1994). J. Biol. Chem., 271, 5422-5429.
22. DeSantes K, Slamon DJ, Anderson S, Shepard M, Fendly B, Maneval D and Press O. (1992). Cancer Res., 52, 1916-1923.
23. DiFiore P, Pierce J, Kraus MH, Segatto O, King CR and Aaronson SA. (1987). Science, 237, 178-181.
24. Dixit M, Yang JL, Poirier MC, Price JO, Andrews PA and Arteaga CL. (1997). J. Natl. Cancer Inst., 89, 365-373.
25. Drebin JA, Link VC and Greene MI. (1988). Oncogene, 2, 387-394.
26. El-Diery W, Tokino T, Velculescu V, Levy D, Parsons R, Trent J, Lin D, Mercer W, Kinzler K and Vogelstein B. (1993). Cell, 75, 817-825.
27. Fendly BM, Winget M, Hudziak RM, Lipari MT, Napier MA and Ullrich A. (1990). Cancer Res., 50, 1550-1558.
28. Graus-Porta D, Beerli R and Hynes N. (1995). Mol. Cell. Biol., 15, 1182-1191.
29. Gusterson BA, Gelber RD, Goldhirsch A, Price KN, Save-Soderborgh J, Anbazhagan R, Styles J, Rudenstam C-M, Golouh R, Reed R, Martinez-Tello F, Tiltman A, Torhorst J, Grigolato P, Bettelheim R, Neville AM, Burki K, Castiglione M, Collins J, Lindtner J and Senn H-J. (1992). J. Clin. Oncol., 10, 1049-1056.
30. Hancock MC, Langton BC, Chan T, Toy P, Monahan JJ, Mischak RP and Shawver EK. (1991). Cancer Res., 51, 4575-4580.
31. Harris J, Lippman M, Veronesi U and Willett W. (1992). N. Engl. J. Med., 327, 473-480.
32. Hudziak RM, Lewis GD, Winget M, Fendly BM, Shepard HM and Ullrich A. (1989). Mol. Cell. Biol., 9, 1165-1172.
33. Hudziak RM, Schlessinger J and Ullrich A. (1987). Proc. Natl. Acad. Sci. USA, 84, 7159-7163.
34. Hofman J, Doppler W, Jakob A, Maly K, Posch L, Uberall F and Grunicke H. (1988). Int. J. Cancer, 42, 382-388.
35. Isonishi S, Andrews P and Howell S. (1990). J. Biol. Chem., 265, 3623-3627.
36. Isonishi S, Hom DK, Thiebaut FB, Mann SC, Andrews PA, Basu A, Lazo JS, Eastman A and Howell SB. (1991). Cancer Res., 51, 5903-5909.
37. Jensen L and Linn S. (1988). Mol. Cell. Biol., 8, 3964-3969.
38. Jones JC, Zhen W, Reed E, Parker RJ, Sancar A and Bohr VA. (1991). J. Biol. Chem., 266, 7101-7107.
39. Kastan M, Onyekwere O, Sidransky D, Vogelstein B and Craig R. (1991). Cancer Res., 51, 6304-6311.
40. Kinzel V, Kaszkin M, Blume A and Richards J. (1990). Cancer Res., 50, 7932-7936.
41. Kraus MH, Popescu NC, Amsbaugh SC and King CR. (1987). EMBO J., 6, 605-610.
42. Kurbacher CM, Wagner U, Kolster B, Andreotti PE, Krebs D and Bruckner HW. (1996). Cancer Letters, 103, 183-189.
43. Lemoine NR, Staddon S, Dickson C, Barnes DM and Gullick WJ. (1990). Oncogene, 5, 237-239.
44. Lewis G, Lofgren J, McMurtrey A, Nuijens A, Fendly B, Bauer K and Sliwkowski M. (1996). Cancer Res., 56, 1457-1465.
45. Liu Y, Martindale J, Gorospe M and Holbrook N. (1996). Cancer Res., 56, 31-35.
46. Lofts FJ and Gullick WJ. (1992). Cancer Treatment and Res., 61, 161-179.
47. Maneval D, Mordenti J, Hutchins B, Scates S, Hansen S, Keith D, Kotts C, Fletcher B, Fendly B, Blank G, Venerlein D, Slamon D, Shepard M and Green J. (1991). J. Nucl. Med., 32, 1837-1842.
48. Marte B, Graus-Porta D, Jeschke M, Fabbro D, Hynes N and Taverna D. (1995). Oncogene, 10, 167-175.
49. McDonald III ER, Wu GS, Waldman T and El-Deiry WS. (1996). Cancer Res., 56, 2250-2255.
50. Mendelsohn J and Fan Z. (1997). J. Natl. Cancer Inst., 89, 341-343.
51. Miller AD and Rosman GJ. (1989). Biotechniques, 7, 980-990.
52. Muss HB, Thor AD, Berry DA, Kute T, Liu ET, Koerner F, Cirrincione CT, Budman DR, Wood WC, Barcos M and Henderson IC. (1994). N. Engl. J. Med., 330, 1260-1266.
53. Nielsen D, Maare C and Skovsgaard T. (1996). Gen. Pharmacol., 27, 251-255.
54. Olson EN, Burgess R and Staudinger J. (1993). Cell Growth Differ., 4, 699-705.
55. Pauletti G, Godolphin W, Press MF and Slamon DJ. (1996). Oncogene, 13, 63-72.
56. Pegram M, Lipton A, Pietras R, Haves D, Weber B, Baselga J, Tripathy D, Twadell T, Glaspy J and Slamon DJ. (1995). Proc. Am. Soc. Clin. Oncol., 14, 106.
57. Pegram M, Finn RS, Arzoo K, Beryt M, Pietras R and Slamon D. (1997). Oncogene, 15, 537-547.
58. Pierce JH, Arnstein P, DiMarco E, Artrip J, Kraus MH, Lonardo F, DiFiore P and Aaronson SA. (1991). Oncogene, 6, 1189-1194.
59. Pietras RJ, Fendly B, Chazin V, Pegram M, Howell S and Slamon D. (1994). Oncogene, 9, 1829-1838.
60. Press MF, Cordon-Cardo C and Slamon DJ. (1990). Oncogene, 5, 953-962.
61. Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W Sliwkowski M, Akita R, Paterson MC and Slamon DJ. (1993). Cancer Res., 53, 4960-4970.
62. Purewal M and Liehr JG. (1993). Cancer Chemother. Pharmacol., 33, 239-244.
63. Reese D and Slamon DJ. (1997). Stem Cells, 15, 1-8.
64. Ro J, El-Naggar A, Ro JY, Blick M, Frye D, Fraschini G, Fritsche H and Hortobagyi G. (1989). Cancer Res., 49, 6941-6944.
65. Sarup JC, Johnson RM, King KL, Fendly BM, Lipari MT, Napier MA, Ullrich A und Shepard HM. (1991). Growth Regulation, 1, 72-82.
66. Sawyer TW, Gill RD, Smith-Oliver T, Butterworth BE and DiGiovanni JD. (1988). Carcinogenesis, 9, 1197-1202.
67. Scanlon K, Kashani-Sabet M, Miyachi H, Sowers L and Rossi J. (1989). Anticancer Res., 9, 1301-1312.
68. Scott GK, Dodson J, Montgomery P, Johnson R, Sarup J, Wong W, Ullrich A, Shepard H and Benz C. (1991). J. Biol. Chem., 266, 14300-14305.
69. Semba K, Kamata N, Toyoshima K and Yamamoto T. (1985). Proc. Natl. Acad. Sci. USA, 82, 6479-6502.
70. Seshadri R, Firgaira FA, Horsfall DJ, McCaul K, Setlur V and Kitchen P. (1993). J. Clin. Oncol., 11, 1936-1942.
71. Shepard HM, Lewis G, Sarup J, Fendly B, Maneval D, Mordenti J, Figari I, Kotts C, Palladino M, Ullrich A and Slamon DJ. (1991). J. Clin. Immunol., 11, 117-127.
72. Slamon DJ, Clark GM, Wong S, Levin W, Ullrich A and McGuire W. (1987). Science, 235, 177-182.
73. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and Press MF. (1989a). Science, 244, 707-712.
74. Slamon DJ, Press MF, Godolphin W, Ramos L, Haran P, Shek L, Stuart SG and Ullrich A. (1989b). Cancer Cells, 7, 371-378.
75. Sorenson CM, Barry MA and Eastman A. (1990). J. Natl. Cancer Inst., 82, 749-755.
76. Soule HD and McGrath CM. (1980). Cancer Letters, 10, 177-189.
77. Tsai C-M, Chang K-T, Perng R-P, Mitsudomi T, Chen M-H, Kadoyama C and Gazdar AF. (1993). J. Natl. Cancer Inst., 85, 897-901.
78. Tsai C-M, Levitzki A, Wu L-H, Chang K-T, Cheng C-C, Gazit A and Perng R-P. (1996). Cancer Res., 56, 1068-1074.
79. Van Diest P, Baak J, Matze-Cok P and Bacus S. (1992). Pathol. Res. Prac., 188, 344-350.
80. Wampler G, Carter W, Campbell E and Keefe P. (1992). Cancer Chemother. Pharmacol., 31, 111-117.
81. Wu GS and El-Deiry S. (1996). Clin. Cancer Res., 2, 623-633.
82. Yarden Y and Ullrich A. (1988). Annu. Rev. Biochem., 57, 443-478.
83. Yen L, Zeng-Rong N, You X-L, Richard S, Langton-Webster BC and Alaoui-Jamali MA. (1997). Oncogene, 14, 1827-1835.
84. Zhang L and Hung M-C. (1996). Oncogene, 12, 571-576.
85. Zhen W, Link CJ, O'Connor PM, Reed E, Parker R, Howell SB and Bohr VA. (1992). Mol. Cell. Biol., 12, 3689-3698.